Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.
about
Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studiesThe challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccineAdvances in Pediatric NeurovirologyHerpes simplex virus internalization into epithelial cells requires Na+/H+ exchangers and p21-activated kinases but neither clathrin- nor caveolin-mediated endocytosis.The C terminus of the large tegument protein pUL36 contains multiple capsid binding sites that function differently during assembly and cell entry of herpes simplex virusHelicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections.Acute encephalitis in children: Progress and priorities from an Australasian perspective.The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization.Evaluation of 98 immunocompetent children with cytomegalovirus infection: importance of neurodevelopmental follow-up.Effectiveness of Early Antiviral Therapy in Disseminated Neonatal Herpes Simplex Virus 2 (HSV-2) with Fulminant Hepatic Failure.Update on herpes virus infections of the nervous system.Methods of rapid diagnosis for the etiology of meningitis in adultsDevelopment of recombinant antigen array for simultaneous detection of viral antibodiesHomeostatic interferon expression in neurons is sufficient for early control of viral infectionCMX001 potentiates the efficacy of acyclovir in herpes simplex virus infectionsTreatment of herpes simplex virus infections in pediatric patients: current status and future needs.Synthesis and antiviral activities of methylenecyclopropane analogs with 6-alkoxy and 6-alkylthio substitutions that exhibit broad-spectrum antiviral activity against human herpesviruses.The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis.The search for new therapies for human cytomegalovirus infections.Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses.Paediatric infectious diseases: the last 50 years.Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections.Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions.Cholestasis caused by panhypopituitarism and acquired cytomegalovirus infection in a 2-month-old male infant: A case report.11.7 T MR Imaging Revealed Dilatation of Virchow-Robin Spaces within Hippocampus in Maternally Lipopolysaccharide-exposed Rats.Corilagin Protects Against HSV1 Encephalitis Through Inhibiting the TLR2 Signaling Pathways In Vivo and In Vitro.A perinatal cytomegalovirus infection in an immunocompetent patient with chorioretinitis.Herpes simplex virus type 1 encephalitis and unusual retinitis in a patient with systemic lupus erythematosus.Herpesviruses in cerebrospinal fluid of children with meningitis in Luanda, Angola.Protective activity of the ethanol extract of Cynanchum paniculatum (BUNGE) Kitagawa on treating herpes simplex encephalitis.Inducing-apoptotic activity of the ethanol extract of Duchesnea indica Focke on treatment of herpes simplex encephalitis.Neuroimaging of pediatric brain infections.Synthesis and anti-HSV-1 evaluation of new 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridines and 3H-pyrido[2,3-b]pyrazolo[3,4-h]-1,6-naphthyridinesDetection of Virus Herpes Simplex Type 1 in Patients with Chronic Periodontal Disease
P2860
Q24629979-66A0321B-191B-45FD-8060-6E06FFCFE0E3Q27021292-CBC6FFCA-FAEF-4911-8E31-3ECDD0AF5130Q27491302-BD3B0C23-06B4-43B4-BC66-F1FE3FC4AE77Q30405542-4A930CB8-15D7-4068-986A-01021D833B1DQ30424771-00362E0C-D106-4B16-BEF5-661D7C94E110Q30720731-39F51804-BFE3-4B5C-8C69-83AD2C0225E1Q30832727-228662C9-BC27-4120-B493-473B02D43F63Q31036498-7BAAF826-C271-4A53-9976-9B2A9EA8B7E8Q33421105-1395A14B-B1AF-4E3E-9F93-B5FB98151437Q33574240-B9CCADFD-8AB6-4245-8AB0-54B9AEF9BFB2Q34379006-456A3F19-A937-406B-AE59-5B62422AC3E1Q34554521-B5BC0B20-89DD-4089-B9E9-8AB8045E8AF3Q34994434-0692A4CF-BBE0-4CF1-B13F-766C98A27A9BQ35075450-7910FA1F-4053-4118-8456-80BB5661DA33Q35270714-A187EE34-FA9E-47C6-AE11-814FC3206A45Q36938445-091E65D9-0CDB-4B77-BBFD-1597E0ACCFE4Q37036545-19AD2A51-0A74-4A06-9612-A9DE1763B463Q37173390-866AC95A-72D3-4B9E-B49A-0AB610382B6AQ37811458-3E0EA873-BC4E-4E80-80B2-A8B1869D5288Q37963480-CEF070F2-6746-42F1-8FC8-666507250A44Q38307034-62D49C9E-725E-43E4-B89C-E6F79C62712FQ38637282-90A7C464-B36B-4EBB-A83E-9947F39B8FB8Q39074863-142C8456-0B94-45CA-B9EA-4387F2D9C22EQ40059507-5E05FCEF-3E3D-4EDD-8099-4D5F9FAAFA71Q40685924-E94F4DA4-2103-4A95-813A-0A09E831B9A0Q41678491-88243DDD-8FE7-4FC5-85A5-DB8CF24DE8A3Q42217606-08C798E1-35D9-44AA-9348-08888189B707Q42274863-D85B1E5C-CF98-4295-982C-FE037BFEAAF7Q46673995-DB8A6FE3-2427-41F6-9CD5-CC0E667DAC02Q48565826-B5CBCA6B-D063-427E-8080-5D908B75DE5BQ48858353-54DFE7FD-08FE-4F21-8B37-03806F99A437Q49145019-9EEEC7F7-06D3-4438-97B2-439B3A81D1A4Q56417915-C14CE0B6-1390-45BD-8BDD-F61503E5BEBAQ58552301-DF5D104E-7A9A-4E08-887C-E92F929DE0BC
P2860
Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiviral therapy for herpesvi ...... tal cytomegalovirus infection.
@en
Antiviral therapy for herpesvi ...... tal cytomegalovirus infection.
@nl
type
label
Antiviral therapy for herpesvi ...... tal cytomegalovirus infection.
@en
Antiviral therapy for herpesvi ...... tal cytomegalovirus infection.
@nl
prefLabel
Antiviral therapy for herpesvi ...... tal cytomegalovirus infection.
@en
Antiviral therapy for herpesvi ...... tal cytomegalovirus infection.
@nl
P2093
P2860
P1433
P1476
Antiviral therapy for herpesvi ...... tal cytomegalovirus infection.
@en
P2093
David W Kimberlin
Richard J Whitley
Scott H James
P2860
P304
P356
10.1016/J.ANTIVIRAL.2009.04.010
P577
2009-05-04T00:00:00Z